tweaking vaccine doses pfizer biontech moderna vaccines involve viral genetic material known mrna given clinical trial participants doses prime dose followed booster weeks later doses found 95 percent effective preventing covid came 94.1 percent trials pfizer vaccine provided partial immunity weeks dose efficacy 82 percent data protection lasts longer weeks second dose given immunological evidence suggests antibody response vaccine increased substantially second dose decisions alternative dosing regimens reside health authorities pfizer believes critical conduct surveillance efforts alternative schedules implemented ensure recipient afforded maximum possible protection means immunization doses vaccine company said statement shared rasmussen agrees line not efficacy support delayed